Laparoscopic Surgery or Minimally Invasive Surgery (MIS) is a surgical technique where a wide variety of procedures being performed on patients. While these procedures have many advantages for patients compared to traditional surgery, they also have common side effects which are the result of the condition of the gas. The gas traditionally used to insufflate the body is carbon dioxide (CO2). The current condition of the gas has been linked to:
– Post-operative shoulder pain and abdominal pain
– Inflammatory response
– Time in recovery
– Lens fogging
HOW OUR TECHNOLOGY IMPROVES PATIENT OUTCOMES
Traditional carbon dioxide (CO2) gas used for insufflation is dry and cold. While most patients and care providers have not thought much about the relative humidity of this gas and its effects on the human body, it has been shown to be profound. The traditional state of the CO2 is drier than desert air and cold relative to the patient’s body. The dry CO2causes drying of the delicate tissues in the body, specifically the peritoneal cells. This results in hypothermia, desiccation, and increased inflammatory response causing patients to experience shoulder pain and other post-operative pain.
The Insuflow® humidifies and warms the CO2 gas to 95°F and 95%RH and has been proven in numerous scientific studies to provide patients the following benefits:
– Less patient pain which means less narcotic pain medication
– Less narcotic pain medication leads to less nausea.
– Less shivering and hypothermia.
– Less damage to tissues leading to decreased inflammatory response
– Shorter recovery time lowers overall hospital stay therefore saving money for the patient and hospital.
NURSES AND SURGEONS
The Insuflow® has been implemented at hospitals and surgery centers across the U.S. for more than 10 years and in many it is their standard of care. The Insuflow® is a compact easy-to-use disposable device that creates the best conditions to perform laparoscopic surgery. It is compatible with all insufflators. The Insuflow® technology has received several patents. The Insuflow® has been cleared for the United States market by FDA and has received the European Union market CE Mark. Please review the clinical studies to see how your patients can benefit from implementing the Insuflow®.
- – Less post-operative pain
- – Reduced hypothermia
- – Improved outcomes
- – Faster and improved recovery times
- – Improved visualization
Please contact us so we can help you have a better surgical experience. We can help provide your surgeon with the Insuflow® during your upcoming laparoscopic surgery so you can get back to enjoying your normal daily activities faster and with less pain!